THOUSAND OAKS, Calif., July 14, 2008 — Biotechnology company Amgen Inc. said Business Wire erroneously released a statement from the company Monday, saying the Food and Drug Administration approved its Nplate treatment for a rare type of...
Source: http://www.drugs.com/new-drug-applications.html
Drugs.com - New Drug Applications